In March 2023, Japan’s Ministry of Health and Labor Welfare approved Novo Nordisk’s once-weekly subcutaneous glucagon-like peptide-1
Take proper precautions and seek timely treatment!
KEYTRUDA plus concurrent chemoradiotherapy demonstrated statistically significant and clinically meaningful improvement in PFS versus concurrent chemoradiotherapy alone in these patients
To equip them with the latest knowledge and skills to handle patients coming to them in a better way
First of its kind screening for Glaucoma at grass root level over 10k screened already
Rare childhood cancer subtype, Ph+ ALL, is found in 3-4% of pediatric cases and 25% of adult cases
SHL Medical announces the acquisition of LCA Automation AG, a Swiss innovative automation solutions provider
The positive safety review from the DSMB enables the trial to move forward as planned, with an estimated completion date in December 2023
The VITA-FAST tokens have been met with overwhelming interest
Currently there are no vaccines approved anywhere in the world for gonorrhoea, and antimicrobial resistance to existing treatments is increasing
Subscribe To Our Newsletter & Stay Updated
